In silico study of Actinium-225 (225AC) labelled pentixafor targeting CXCR4 and genetic dependency for breast cancer therapy.
Saved in:
| Title: | In silico study of Actinium-225 (225AC) labelled pentixafor targeting CXCR4 and genetic dependency for breast cancer therapy. |
|---|---|
| Authors: | Kurniawan, Ahmad1 (AUTHOR) ahmad.kurniawan@brin.go.id, Nurmanjaya, Ahid1 (AUTHOR) ahid001@brin.go.id, Setiadi, Yanuar2 (AUTHOR) yanu007@brin.go.id, Febrian, Muhamad Basit1 (AUTHOR) muha121@brin.go.id |
| Source: | AIP Conference Proceedings. 2024, Vol. 2967 Issue 1, p1-8. 8p. |
| Database: | Academic Search Ultimate |
| ISSN: | 0094243X |
|---|---|
| DOI: | 10.1063/5.0193076 |
